Isodiol International Inc. Commences Approval Process to Bring Isodiol to Chilean Market Biotech Investing
Emblem Announces Exclusive Agreement with Canntab Therapeutics for Cannabinoid Based Oral Sustained Release Formulation Cannabis Investing News
3D Signatures Announces Private Placement With Strategic Partner and Prospectus Update Biotech Investing
Revive Therapeutics Enters into Research Collaboration with Sanyal Biotechnology for Liver Diseases Biotech Investing
Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Trial for Fully Proprietary Lead IO Program, PRS-343 Pharmaceutical Investing
